Basic Information
| RNALocate ID: | RLID-D:11000039 |
| RNA Symbol: | hsa-miR-199a-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-199a-3p |
| RNA ID: | miRBase:MIMAT0000232 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Blood|Endothelial cells |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001566 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11001286 | Exosome | Peripheral blood mononuclear cells | 19002258 |
| RLID:11001287 | Exosome | Brain tissue | 23382797 |
| RLID:11001288 | Exosome | Plasma | 23663360 |
| RLID:11001289 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID:11001290 | Extracellular Vesicle | Liposarcoma cell lines (Lipo224B|Lipo246|Lipo863|LPS141)|Preadipocytes | 28588009 |
| RLID:11001291 | Microvesicle | Plasma | 19002258 |
| RLID:11001292 | Microvesicle | Plasma | 23077538 |
| RLID:11001293 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000308 | Microvesicle | Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-199a-3p | Colorectal adenoma | MNDR-E-MI-24718 |
| MNDR | hsa-miR-199a-3p | Oral squamous cell carcinoma | MNDR-E-MI-24719 |
| MNDR | hsa-miR-199a-3p | Medulloblastoma | MNDR-E-MI-24720 |
| MNDR | hsa-miR-199a-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-24721 |
| MNDR | hsa-miR-199a-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-24722 |
| MNDR | hsa-miR-199a-3p | Non-hodgkin lymphoma | MNDR-E-MI-24723 |
| MNDR | hsa-miR-199a-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-24724 |
| MNDR | hsa-miR-199a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-24725 |
| MNDR | hsa-miR-199a-3p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-24726 |
| MNDR | hsa-miR-199a-3p | Dermatomyositis | MNDR-E-MI-24727 |
| MNDR | hsa-miR-199a-3p | Prostate cancer | MNDR-E-MI-24728 |
| MNDR | hsa-miR-199a-3p | Gastric cancer | MNDR-E-MI-24729 |
| MNDR | hsa-miR-199a-3p | Alzheimer disease | MNDR-E-MI-24730 |
| MNDR | hsa-miR-199a-3p | Bladder cancer | MNDR-E-MI-24731 |
| MNDR | hsa-miR-199a-3p | Dysautonomia familial | MNDR-E-MI-24732 |
| MNDR | hsa-miR-199a-3p | Distal muscular dystrophy | MNDR-E-MI-24733 |
| MNDR | hsa-miR-199a-3p | Duchenne muscular dystrophy | MNDR-E-MI-24734 |
| MNDR | hsa-miR-199a-3p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-24735 |
| MNDR | hsa-miR-199a-3p | Head and neck cancer | MNDR-E-MI-24736 |
| MNDR | hsa-miR-199a-3p | Leukemia | MNDR-E-MI-24737 |
| MNDR | hsa-miR-199a-3p | Huntington disease | MNDR-E-MI-24738 |
| MNDR | hsa-miR-199a-3p | Chorea | MNDR-E-MI-24739 |
| MNDR | hsa-miR-199a-3p | Lung cancer | MNDR-E-MI-24740 |
| MNDR | hsa-miR-199a-3p | Parkinson disease | MNDR-E-MI-24741 |
| MNDR | hsa-miR-199a-3p | Breast cancer | MNDR-E-MI-24742 |
| MNDR | hsa-miR-199a-3p | Cancer | MNDR-E-MI-24743 |
| MNDR | hsa-miR-199a-3p | Thyroid cancer | MNDR-E-MI-24744 |
| MNDR | hsa-miR-199a-3p | Pancreatic cancer | MNDR-E-MI-24745 |
| MNDR | hsa-miR-199a-3p | HCV | MNDR-E-MI-24746 |
| MNDR | hsa-miR-199a-3p | Malignant melanoma | MNDR-E-MI-24747 |
| MNDR | hsa-miR-199a-3p | Rectum adenocarcinoma | MNDR-E-MI-24748 |
| MNDR | hsa-miR-199a-3p | Colon adenocarcinoma | MNDR-E-MI-24749 |
| MNDR | hsa-miR-199a-3p | Multiple sclerosis | MNDR-E-MI-24750 |
| MNDR | hsa-miR-199a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-24751 |
| MNDR | hsa-miR-199a-3p | Familial ovarian cancer | MNDR-E-MI-24752 |
| MNDR | hsa-miR-199a-3p | Prostate adenocarcinoma | MNDR-E-MI-24753 |
| MNDR | hsa-miR-199a-3p | Kidney cancer | MNDR-E-MI-24754 |
| MNDR | hsa-miR-199a-3p | Glioblastoma | MNDR-E-MI-24755 |
| MNDR | hsa-miR-199a-3p | Glioma | MNDR-E-MI-24756 |
| MNDR | hsa-miR-199a-3p | Nemaline myopathy | MNDR-E-MI-24757 |
| MNDR | hsa-miR-199a-3p | Osteosarcoma | MNDR-E-MI-24758 |
| MNDR | hsa-miR-199a-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-24759 |
| MNDR | hsa-miR-199a-3p | Meningioma | MNDR-E-MI-24760 |
| MNDR | hsa-miR-199a-3p | Cervical adenocarcinoma | MNDR-E-MI-24761 |
| MNDR | hsa-miR-199a-3p | Gastric adenocarcinoma | MNDR-E-MI-24762 |
| MNDR | hsa-miR-199a-3p | Cervical squamous cell carcinoma | MNDR-E-MI-24763 |
| MNDR | hsa-miR-199a-3p | Lung squamous cell carcinoma | MNDR-E-MI-24764 |
| MNDR | hsa-miR-199a-3p | Lung adenocarcinoma | MNDR-E-MI-24765 |
| MNDR | hsa-miR-199a-3p | Adrenocortical cancer | MNDR-E-MI-24766 |
| MNDR | hsa-miR-199a-3p | Thyroid carcinoma | MNDR-E-MI-24767 |
| MNDR | hsa-miR-199a-3p | Papillary thyroid carcinoma | MNDR-E-MI-24768 |
| MNDR | hsa-miR-199a-3p | Ovarian carcinoma | MNDR-E-MI-24769 |
| MNDR | hsa-miR-199a-3p | Bladder urothelial carcinoma | MNDR-E-MI-24770 |
| MNDR | hsa-miR-199a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-24771 |
| MNDR | hsa-miR-199a-3p | Liver disease | MNDR-E-MI-24772 |
| MNDR | hsa-miR-199a-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-24773 |
| MNDR | hsa-miR-199a-3p | Carcinoma renal cell | MNDR-E-MI-24774 |
| MNDR | hsa-miR-199a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-24775 |
| MNDR | hsa-miR-199a-3p | Clear cell renal cell cancer | MNDR-E-MI-24776 |
| MNDR | hsa-miR-199a-3p | Chromophobe renal cell carcinoma | MNDR-E-MI-24777 |
| MNDR | hsa-miR-199a-3p | Adenocarcinoma of esophagus | MNDR-E-MI-24778 |
| MNDR | hsa-miR-199a-3p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-24779 |
| MNDR | hsa-miR-199a-3p | Esophageal cancer | MNDR-E-MI-24780 |
| MNDR | hsa-miR-199a-3p | Oncocytoma | MNDR-E-MI-24781 |
| MNDR | hsa-miR-199a-3p | Lung small cell carcinoma | MNDR-E-MI-24782 |
| MNDR | hsa-miR-199a-3p | Synovial sarcoma | MNDR-E-MI-24783 |
| MNDR | hsa-miR-199a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-24784 |
| MNDR | hsa-miR-199a-3p | Acute heart failure | MNDR-E-MI-24785 |
| MNDR | hsa-miR-199a-3p | Uveal melanoma | MNDR-E-MI-24786 |
| MNDR | hsa-miR-199a-3p | Fibromyalgia | MNDR-E-MI-24787 |
| MNDR | hsa-miR-199a-3p | Adenoma | MNDR-E-MI-24788 |
| MNDR | hsa-miR-199a-3p | Hepatocellular carcinoma | MNDR-E-MI-24789 |
| MNDR | hsa-miR-199a-3p | Familiar ovarian carcinoma | MNDR-E-MI-24790 |
| MNDR | hsa-miR-199a-3p | B-cell lymphoma | MNDR-E-MI-24791 |
| MNDR | hsa-miR-199a-3p | Retinoblastoma | MNDR-E-MI-24792 |
| MNDR | hsa-miR-199a-3p | Barrett's adenocarcinoma | MNDR-E-MI-24793 |
| MNDR | hsa-miR-199a-3p | Hodgkin lymphoma | MNDR-E-MI-24794 |
| MNDR | hsa-miR-199a-3p | Ulcerative colitis | MNDR-E-MI-24795 |
| MNDR | hsa-miR-199a-3p | Burkitt lymphoma | MNDR-E-MI-24796 |
| MNDR | hsa-miR-199a-3p | Tonsil cancer | MNDR-E-MI-24797 |
| MNDR | hsa-miR-199a-3p | Acute myeloid leukemia | MNDR-E-MI-24798 |
| MNDR | hsa-miR-199a-3p | Colorectal cancer | MNDR-E-MI-24799 |
| MNDR | hsa-miR-199a-3p | Nasopharynx carcinoma | MNDR-E-MI-24800 |
| MNDR | hsa-miR-199a-3p | Cardiomegaly | MNDR-E-MI-24801 |
| MNDR | hsa-miR-199a-3p | Nasopharyngeal cancer | MNDR-E-MI-24802 |
| MNDR | hsa-miR-199a-3p | Prostatic neoplasms | MNDR-E-MI-24803 |
| MNDR | hsa-miR-199a-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-24804 |
| MNDR | hsa-miR-199a-3p | Stroke lacunar | MNDR-E-MI-24805 |
| MNDR | hsa-miR-199a-3p | Barrett's carcinogenesis | MNDR-E-MI-24806 |
| MNDR | hsa-miR-199a-3p | Breast cancer her3+ negative | MNDR-E-MI-24807 |
| MNDR | hsa-miR-199a-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-24808 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | APOE | Homo sapiens | RR00090972 |
TOP